Philips Handheld Diagnostics

Near patient blood testing

Today’s challenge is to simplify healthcare procedures to enhance the quality of patient care, while keeping costs viable. Philips aims to empower physicians with patient centric solutions that can provide relevant information to make near patient diagnoses.

Changes in workflow

There is already a trend away from centralized treatment and testing, which focuses primarily on acute and late interventions, towards more patient-friendly care, at the patient's bedside. It is predicted that within 10 years, some complex IVD blood assays will have shifted from laboratory to near patient settings.

'Our aim is to save lives and return patients to the best level of health in the shortest time.'

Professor Per Venge, Clinical Chemistry, Uppsala Sweden

Innovation in biosensor nanotechnology

The use of magnetic nano particles enables the Magnotech technology to measure minute concentrations of target molecules: at a sensitivity more than 500 million times of a glucose test.

Results within minutes

Philips is developing the breakthrough Minicare system with the aim of delivering lab-equivalent test results at point-of-care — within minutes.